Back to All Events

Toxic Tears: Recognizing and Managing Preservative-Induced Damage

 
 

Dry Eye Disease is a complex, often-overlooked condition. This course promotes proactive diagnosis and care, with special attention to ocular toxicities related to preservatives, offering advanced tools, technologies, and strategies to improve outcomes across all eyecare specialties.

Almost 1400 attended our event and we received amazing feedback!

Feedback from anonymous survey:

  • I loved the anatomy portion and nerd- out moments. I wish we had touched more on surface dysbiosis and the role of immunosuppressants on OSD

  • Great speaker! Will definitely look forward to finding her lectures again. I work in long term care facilities and this information is invaluable! Thank you!!

  • Thanks for the amazing talk! Such a knowledgeable speaker!

  • No one better than Dr. McGee! Just bought a bottle of Ivizia drops today. Synchronicity!

  • Extremely interesting lecture with valuable clinical information and solutions.

  • Good pacing and enjoyed the first hand advice on what worked for her.

  • Great speaker! Great subject that is a largely ignored subject.

  • Woo U is my FAVORITE CE source! Thank you.

  • Dr. McGee was very knowledgeable and engaging. Excellent info presented tonight.

  • Great speaker - loved your clinical pearls such as probing further to get true patient history, and using proparacaine to distinguish central from peripheral pain.

  • I will now switch my own drops to only preservative free.

  • Liked the case about GLP use because our patients often do not share.

  • Very convenient and much improved system.

  • McGee is always so fantastic. Extremely knowledgeable and teaches very well!

Speaker: Selina McGee, OD, FAAO

Moderator: Dr. Elise Kramer

COPE ID: 106586-TD

Category: Trt/Mngmnt Ocular Disease

This event is COPE approved for 1 hour of CE credit.

Thank you to Thea for exhibiting at this event.

Thank you to Thea for exhibiting at this event.

Established in 2019, Thea Pharma is the United States subsidiary of Laboratoires Théa, a global leader and pioneer in ophthalmics. We are committed to serve doctors that treat the anterior segment and ocular surface conditions.

Previous
Previous
September 24

Demystifying Medication Access

Next
Next
October 7

Scleral Lens Extravaganza: Advanced Technology, Troubleshooting and Cases